3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
8
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Sarcoma, Ewing
2
Neuroblastoma
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Central Nervous System Neoplasms
2
Uterine Cervical Neoplasms
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Choroid Plexus Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Specimen Handling
4
Biopsy
4
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
venetoclax
1
tocilizumab
1
ruxolitinib
1
peginterferon alfa-2b
1
iadademstat
1
fludarabine
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Idarubicin
1
Hyperbaric Oxygenation
1
Filgrastim
1
Etoposide
1
Cytarabine
1
Cyclosporins
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Topotecan
×
30 days
×
Clear all
No trials found.